We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$5.56B
AUM Growth
+$273M
Cap. Flow
+$119M
Cap. Flow %
2.13%
Top 10 Hldgs %
28.06%
Holding
379
New
20
Increased
141
Reduced
127
Closed
12

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$52.6M
2
LMT icon
Lockheed Martin
LMT
+$50.9M
3
SE
Spectra Energy Corp Wi
SE
+$38M
4
PAYX icon
Paychex
PAYX
+$27.7M
5
AAPL icon
Apple
AAPL
+$24.8M

Top Sells

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$37.7M
2
RTX icon
RTX Corp
RTX
+$32.6M
3
KMI icon
Kinder Morgan
KMI
+$30.9M
4
DLR icon
Digital Realty Trust
DLR
+$27.6M
5
NNN icon
NNN REIT
NNN
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 15.97%
2 Consumer Staples 15.67%
3 Healthcare 14.85%
4 Energy 12.26%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLH
201
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
$805K 0.01%
15,235
+50
+0.3% +$2.74K
FDS icon
202
Factset
FDS
$9.74B
$800K 0.01%
7,335
ETP
203
DELISTED
Energy Transfer Partners L.p.
ETP
$791K 0.01%
15,197
+47
+0.3% +$2.42K
SNY icon
204
Sanofi
SNY
$103B
$788K 0.01%
15,568
+338
+2% +$17.2K
CHE icon
205
Chemed
CHE
$7.03B
$776K 0.01%
10,849
-3,000
-22% -$213K
XEC
206
DELISTED
CIMAREX ENERGY CO
XEC
$758K 0.01%
7,860
+125
+2% +$10.1K
PFM icon
207
Invesco Dividend Achievers ETF
PFM
$801M
$757K 0.01%
40,840
+1,056
+3% +$19.7K
ZTS icon
208
Zoetis
ZTS
$32B
$742K 0.01%
23,840
+298
+1% +$9.13K
RMD icon
209
ResMed
RMD
$31.9B
$737K 0.01%
+13,955
New +$677K
DRI icon
210
Darden Restaurants
DRI
$23.4B
$721K 0.01%
17,430
-4,615
-21% -$200K
SCL icon
211
Stepan Co
SCL
$1.45B
$715K 0.01%
12,390
+50
+0.4% +$2.9K
MDY icon
212
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$700K 0.01%
3,093
-100
-3% -$22.2K
EWS icon
213
iShares MSCI Singapore ETF
EWS
$1.06B
$695K 0.01%
26,018
EMN icon
214
Eastman Chemical
EMN
$8.35B
$693K 0.01%
8,894
+2,520
+40% +$194K
DHR icon
215
Danaher
DHR
$138B
$654K 0.01%
14,030
-804
-5% -$36.5K
IWM icon
216
iShares Russell 2000 ETF
IWM
$82.8B
$645K 0.01%
6,051
+659
+12% +$68.2K
NNN icon
217
NNN REIT
NNN
$8.98B
$636K 0.01%
19,972
-792,039
-98% -$26.4M
CMD
218
DELISTED
Cantel Medical Corporation
CMD
$628K 0.01%
19,721
-4
-0% -$106
LYB icon
219
LyondellBasell Industries
LYB
$19.4B
$626K 0.01%
8,550
+3,250
+61% +$226K
SSYS icon
220
Stratasys
SSYS
$759M
$621K 0.01%
6,135
+215
+4% +$20.8K
BEAM
221
DELISTED
BEAM INC COM STK (DE)
BEAM
$611K 0.01%
9,456
+3,000
+46% +$193K
BUD icon
222
AB InBev
BUD
$166B
$585K 0.01%
5,900
-130
-2% -$12.4K
EPD icon
223
Enterprise Products Partners
EPD
$81.9B
$569K 0.01%
18,658
+1,146
+7% +$35K
HSY icon
224
Hershey
HSY
$35.7B
$561K 0.01%
6,070
TXRH icon
225
Texas Roadhouse
TXRH
$13.8B
$553K 0.01%
21,040
+2,450
+13% +$61.6K

Similar funds

Bahl & Gaynor's Q3 2013 Portfolio in Review

As of Q3 2013, Bahl & Gaynor held 379 positions worth $5.56B, up 5.2% from $5.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bahl & Gaynor's Q3 2013 filing shows 20 new, 141 increased, 127 reduced and 12 closed positions. Its largest new stake was iShares Core High Dividend ETF: 172,920 shares worth $2.29M. The largest sale was Scotiabank, an estimated $37.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Bahl & Gaynor's largest Q3 2013 buy was iShares Core High Dividend ETF: 172,920 shares worth $2.29M.
  • Bahl & Gaynor added most to Cullen/Frost Bankers in Q3 2013, an estimated $52.6M increase.
  • Bahl & Gaynor's biggest Q3 2013 reduction was Scotiabank, cutting an estimated $37.7M.
  • Bahl & Gaynor fully exited SM Energy in Q3 2013, selling an estimated $539K.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $5.56B portfolio in Q3 2013.
  • Bahl & Gaynor opened 20 new positions and closed 12 in Q3 2013.
  • Bahl & Gaynor's portfolio value rose 5.2% quarter-over-quarter to $5.56B.

Based on Bahl & Gaynor's 13F filing for Q3 2013, filed 13 Nov 2013.